Aldurazyme Prices, Coupons and Patient Assistance Programs
Aldurazyme (laronidase) is a member of the lysosomal enzymes drug class and is commonly used for Mucopolysaccharidosis Type I.
The cost for Aldurazyme intravenous solution (2.9 mg/5 mL) is around $1,003 for a supply of 5 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This Aldurazyme price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.Print Free Discount Card
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Aldurazyme Coupons and Rebates
Aldurazyme offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Aldurazyme Charitable Access Program (CAP): Program provides medication to patients who medically need it and are uninsured or underinsured; for additional information contact the program at 800-745-4447, option 3.
|Number of uses:||Per prescription until program expires|
Aldurazyme CareConnectPSS Co-Pay Assistance Program: Program will cover 100% of out-of-pocket costs for eligible commercially insured patients; for additional information contact the program at 800-745-4447, option 3.
|Number of uses:||12 times within calendar year|
Patient Assistance Programs for Aldurazyme
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Sanofi Genzyme Charitable Access ProgramElligibility requirements:
- Determined case by case
- Not disclosed
- FDA-approved diagnosis
- Must be treated by US licensed healthcare provider
- Resources for HEALTHCARE PROFESSIONALS ONLY. Qualified individuals with Lysosomal Storage Disorders (Gaucher Disease, Fabry Disease, MPS1 and Pompe Disease) whose physicians have recommended treatment may be eligible for this program. This is considered a temporary funding program. Patients and their families are expected to continue exploring alternative resources with the assistance of a Sanofi Genzyme case manager.
- Aldurazyme (laronidase) Injection; IV
More about Aldurazyme (laronidase)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- En Español
- Drug class: lysosomal enzymes
- FDA Alerts (1)